MedTrace Logo

Cardiometabolic Disease and Substrate Metabolism

NCT07565727 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2026-05-04

No results posted yet for this study

Summary

This study's primary purpose is to determine the potential relationship between cardiometabolic disease, specifically insulin resistance (HOMA-IR), and maternal lipid oxidation.

Conditions

  • Preeclampsia
  • Gestational Diabetes Mellitus (GDM)
  • Preeclampsia (PE)
  • Preeclampsia (PE) Risk
  • Gestational Diabetes
  • Gestational Diabetes Mellitus in Pregnancy
  • Cardiometabolic Diseases
  • Insulin Resistance
  • Placental Dysfunction
  • Pregnancy
  • Pregnancy Complications
  • Gestational Complications

Sponsors & Collaborators

  • University of Tennessee Graduate School of Medicine

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-10
Primary Completion
2026-08-31
Completion
2027-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07565727 on ClinicalTrials.gov